Transconjunctival botulinum toxin injection into the lacrimal gland in crocodile tears syndrome

Simple item page
dc.contributor.authorPattanayak, Sabyasachien_US
dc.contributor.authorSharma, Pramod Kumaren_US
dc.contributor.authorSamikhya, Swatien_US
dc.contributor.authorKhuntia, Ipsitaen_US
dc.contributor.authorPatra, Kalyanien_US
dc.date.accessioned2023-08-25T06:32:39Z
dc.date.available2023-08-25T06:32:39Z
dc.date.issued2022-04
dc.description.abstractPurpose: To determine the efficacy and safety of botulinum toxin injection into the lacrimal gland as a symptomatic treatment of crocodile tear syndrome (CTS). Methods: Our study included six patients of unilateral gustatory hyper lacrimation following either an episode of facial paralysis or post trauma or any related surgery that posed a risk of damaging the facial nerve. Detailed history regarding previous trauma, duration of facial paralysis, previous significant surgery, and duration of steroid use following facial paralysis was noted. Schirmer抯 test was done at baseline and 3 months follow?up. Patients� consent was taken prior to treatment with botulinum toxin injection in the lacrimal gland. Repeat injection of 5 U botulinum toxin (type A) was administered into the lacrimal gland of all patients transconjunctivally within an interval of 1 week. All patients were followed up with Schirmer抯 test at 6 weeks and 3 months. Any complications during treatment were recorded. Results: All six patients showed complete or partial disappearance of reflex lacrimation while chewing following botulinum injection measured by a significant reduction in Schirmer抯 value. When comparing Schirmer test values before (27.8 � 3.58 mm) and after (11.6 � 2.28 mm) BTX?A injection, the differences observed (P = 0.002) were statistically significant (P < 0.05). Only two patients developed mild transitory ptosis. No other complications were noted. Conclusion: Transconjunctival botulinum toxin injection into the lacrimal gland is an effective and safe method to decrease reflex lacrimation during eating or chewing in CTS or gustatory hyper?lacrimation syndrome.en_US
dc.identifier.affiliationsSenior Consultant, Department of Ophthalmology, RGH Rourkela, Odisha, Indiaen_US
dc.identifier.affiliationsDepartment of Ophthalmology, VSS Institute of Medical Science and Research, VIMSAR, Burla, Sambalpur, Odisha, Indiaen_US
dc.identifier.affiliationsConsultant Ophthalmologist, Department of Ophthalmology, DHH Sambalpur, Odisha, Indiaen_US
dc.identifier.citationPattanayak Sabyasachi, Sharma Pramod Kumar, Samikhya Swati, Khuntia Ipsita, Patra Kalyani. Transconjunctival botulinum toxin injection into the lacrimal gland in crocodile tears syndrome. Indian Journal of Ophthalmology. 2022 Apr; 70(4): 1339-1342en_US
dc.identifier.issn1998-3689
dc.identifier.issn0301-4738
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/224256
dc.languageenen_US
dc.publisherAll India Ophthalmological Societyen_US
dc.relation.issuenumber4en_US
dc.relation.volume70en_US
dc.source.urihttps://doi.org/10.4103/ijo.IJO_2909_21en_US
dc.subjectBotulinum toxinen_US
dc.subjectcrocodile tears syndromeen_US
dc.subjectgustatory hyper lacrimation syndromeen_US
dc.titleTransconjunctival botulinum toxin injection into the lacrimal gland in crocodile tears syndromeen_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
IJO2022v70n4p1339.pdf
Size:
1.42 MB
Format:
Adobe Portable Document Format
Download
Collections
Indian Journal of Ophthalmology